Abbott Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ABBOTT, and what generic and branded alternatives to ABBOTT drugs are available?
ABBOTT has one hundred and eleven approved drugs.
Drugs and US Patents for Abbott
Expired US Patents for Abbott
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbott | DEPAKOTE CP | divalproex sodium | TABLET, DELAYED RELEASE;ORAL | 019794-002 | Jul 11, 1990 | 5,212,326*PED | ⤷ Sign Up |
Abbott | HYTRIN | terazosin hydrochloride | TABLET;ORAL | 019057-002 | Aug 7, 1987 | 5,294,615 | ⤷ Sign Up |
Abbott | DEPAKOTE CP | divalproex sodium | TABLET, DELAYED RELEASE;ORAL | 019794-001 | Jul 11, 1990 | 4,988,731*PED | ⤷ Sign Up |
Abbott | HYTRIN | terazosin hydrochloride | TABLET;ORAL | 019057-002 | Aug 7, 1987 | 5,412,095 | ⤷ Sign Up |
Abbott | HYTRIN | terazosin hydrochloride | TABLET;ORAL | 019057-001 | Aug 7, 1987 | 5,212,176 | ⤷ Sign Up |
Abbott | HYTRIN | terazosin hydrochloride | TABLET;ORAL | 019057-004 | Aug 7, 1987 | 4,251,532 | ⤷ Sign Up |
Abbott | MERIDIA | sibutramine hydrochloride | CAPSULE;ORAL | 020632-002 | Nov 22, 1997 | 4,929,629*PED | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ABBOTT drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Tablets | 100 mg | ➤ Subscribe | 2010-12-21 |
➤ Subscribe | Capsules | 10 mg and 15 mg | ➤ Subscribe | 2009-08-14 |
➤ Subscribe | Capsules | 100 mg | ➤ Subscribe | 2012-10-31 |
Similar Applicant Names
Here is a list of applicants with similar names.